Aztreonam

Public Advisory - Two lots of cystic fibrosis drug Cayston recalled due to the potential of cracked glass vials

Retrieved on: 
Saturday, March 18, 2023
DIN, Sodium chloride, Sepsis, Abscess, Health status of Asian Americans, Urinary tract infection, Pharmacy, Patient, Risk, Cystic fibrosis, Health, Health Canada, Glass, Pneumonia, Pharmaceutical industry, Medical device, Aztreonam

Health Canada is advising the public that Gilead Sciences Incorporated recalled two lots (032168 and 033357) of the cystic fibrosis drug Cayston (aztreonam) (DIN 02329840) on March 1, 2023 , due to the potential of cracked glass vials in those lots, which may introduce glass particles into the medication.

Key Points: 
  • Health Canada is advising the public that Gilead Sciences Incorporated recalled two lots (032168 and 033357) of the cystic fibrosis drug Cayston (aztreonam) (DIN 02329840) on March 1, 2023 , due to the potential of cracked glass vials in those lots, which may introduce glass particles into the medication.
  • A cracked glass vial could cause potential injury or lead to potential contamination or a reduced dose.
  • Cayston is a prescription antibacterial medicine used for the management of chronic infections in cystic fibrosis patients.
  • The manufacturer has not received any customer complaints in relation to cracked glass vials in the recalled lots, or any other Cayston lots distributed in Canada.

Generic Pharmaceuticals Global Markets Report 2022: Focus on CNS; Cardiovascular; Dermatology; Genitourinary/Hormonal; Respiratory; Rheumatology; Diabetes; Oncology - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 16, 2022
Health, Pharmaceutical, Code, Time, CNS, US Foods, Canadian International Council, FDA, Patent, Rheumatology, Pharmacist, GSK, The One, Safety, World, Acarbose, Death, Technology, Method, Dermatology, WHO, CVS, Taste, Pharmacy, Conditional sentence, Aztreonam, Research, Distribution, CGMP, Tablet, Marketing, Advertising, HEALTH, 3D, World Health Organization, Pharmacology, Parkinson's disease, Incidence, Food, Acebutolol, Patient, CFR, Metformin, Awareness, Food and Drug Administration, Metoprolol, Diabetes, Biosimilar, Pharmaceutical industry, Generic drug, Medical device, Dietary supplement, GlaxoSmithKline

Generic drugs are manufactured after the expiration of the exclusive rights or patent of the branded drugs.

Key Points: 
  • Generic drugs are manufactured after the expiration of the exclusive rights or patent of the branded drugs.
  • For example, some of the generic drugs in the generic pharmaceuticals market include metformin, metoprolol, acarbose, acebutolol, aztreonam and many more.
  • The main types of generic pharmaceuticals are biosimilar; simple generic and super generic.
  • The low cost and same chemical composition and strength of generic drugs make a patient buy generic drugs instead of branded drugs.

Global Aztreonam Injection Market (2020 to 2025) - Impact of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Friday, May 22, 2020
Health, Pharmaceutical, RTT, Thiazoles, Aztreonam, Organic chemistry

This report is a professional and in-depth study on the current state of the global Aztreonam Injection market with a focus on the Chinese market.

Key Points: 
  • This report is a professional and in-depth study on the current state of the global Aztreonam Injection market with a focus on the Chinese market.
  • Key points of Aztreonam Injection Market Report:
    The report provides a basic overview of Aztreonam Injection industry including: definition, applications and manufacturing technology.
  • The global Aztreonam Injection market is further divided by company, by country, and by application/type for the competitive landscape analysis.
  • Overall, the report provides an in-depth insight of the 2015-2025 global and Chinese Aztreonam Injection market covering all important parameters.